Phantomics officially signed a distribution partnership agreement with Getz Healthcare Thailand. Phantomics has been exploring healthcare synergies with Getz Healthcare for the past year, and has continued its fruitful collaboration across the Asia-Pacific region. 

With the recent receiving a medical device marketing authorization from the Thai Food and Drug Administration (TFDA) for Phantomics' non-invasive cardiomyopathy diagnostic solution, Myomics, this partnership will position Phantomics as an official partner in Thailand, the ASEAN healthcare hub.